ENO2 and COVID-19: It has been shown that children with neurological symptoms in COVID-19 (e.g., headaches, consciousness disturbances, and seizures) had significantly higher levels of NSE compared to the group without complications [34], and elevated NSE levels were observed in patients with severe pulmonary failure, often requiring respiratory support [35].